A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Haemonetics Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 42,000 shares of HAE stock, worth $3.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,000
Previous 55,500 24.32%
Holding current value
$3.59 Million
Previous $4.59 Million 26.49%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.45 - $91.58 $978,075 - $1.24 Million
-13,500 Reduced 24.32%
42,000 $3.38 Million
Q2 2024

Aug 09, 2024

BUY
$81.24 - $97.37 $4.51 Million - $5.4 Million
55,500 New
55,500 $4.59 Million
Q4 2023

Feb 13, 2024

SELL
$80.59 - $92.61 $8.37 Million - $9.61 Million
-103,800 Reduced 72.94%
38,500 $3.29 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $5.85 Million - $6.63 Million
70,900 Added 99.3%
142,300 $12.7 Million
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $5.35 Million - $5.92 Million
66,200 Added 1273.08%
71,400 $6.08 Million
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $145,500 - $181,200
2,000 Added 62.5%
5,200 $430,000
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $236,319 - $275,648
3,200 New
3,200 $252,000
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $886,860 - $1.19 Million
18,000 Added 81.45%
40,100 $2.61 Million
Q1 2022

May 13, 2022

BUY
$43.77 - $63.22 $967,317 - $1.4 Million
22,100 New
22,100 $1.4 Million
Q4 2021

Feb 11, 2022

SELL
$49.55 - $74.59 $6.43 Million - $9.68 Million
-129,785 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $27.1 Million - $33.2 Million
-470,709 Reduced 78.39%
129,785 $9.16 Million
Q2 2021

Aug 13, 2021

SELL
$51.81 - $118.56 $35.2 Million - $80.6 Million
-679,600 Reduced 53.09%
600,494 $40 Million
Q1 2021

May 13, 2021

SELL
$111.01 - $139.48 $32.9 Million - $41.3 Million
-296,100 Reduced 18.79%
1,280,094 $142 Million
Q4 2020

Feb 10, 2021

SELL
$88.75 - $119.95 $31.8 Million - $42.9 Million
-357,991 Reduced 18.51%
1,576,194 $187 Million
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $19.2 Million - $23.7 Million
-253,600 Reduced 11.59%
1,934,185 $169 Million
Q2 2020

Aug 13, 2020

BUY
$84.96 - $118.91 $288,864 - $404,294
3,400 Added 0.16%
2,187,785 $196 Million
Q1 2020

May 14, 2020

SELL
$74.34 - $121.82 $19 Million - $31.1 Million
-255,431 Reduced 10.47%
2,184,385 $218 Million
Q4 2019

Feb 13, 2020

SELL
$114.37 - $129.46 $21.4 Million - $24.2 Million
-187,084 Reduced 7.12%
2,439,816 $280 Million
Q3 2019

Nov 13, 2019

BUY
$117.16 - $138.52 $16.7 Million - $19.7 Million
142,500 Added 5.74%
2,626,900 $331 Million
Q2 2019

Aug 12, 2019

BUY
$81.74 - $120.34 $8.89 Million - $13.1 Million
108,700 Added 4.58%
2,484,400 $299 Million
Q1 2019

May 14, 2019

SELL
$83.25 - $102.12 $3.65 Million - $4.48 Million
-43,900 Reduced 1.81%
2,375,700 $208 Million
Q4 2018

Feb 13, 2019

BUY
$90.66 - $116.63 $219 Million - $282 Million
2,419,600 New
2,419,600 $242 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.